Skip to main content
. 2015 Jan;34(1):17–27. doi: 10.5732/cjc.014.10274

Figure 1. Critical steps in epithelial ovarian cancer care.

Figure 1.

CDDP + CTX: cisplatin and cyclophosphamide[7]; CDDP + PAC: cisplatin and paclitaxel[8],[9]; CBCDA + PAC: carboplatin and paclitaxel[10],[11]; CBCDA-PAC + BEVACIZUMAB: carboplatin, paclitaxel, and bevacizumab[41],[42]; TKi: tyrosin-kinase inhibitors; PARPi: poly(ADP-ribose) polymerase inhibitors; MEKi: mitogen-activated protein/extracellular signal-regulated kinase inhibitors.